Thomas Stephen Basil sold CLYM
February 13, 2026 · Form 4 insider transaction
Thomas Stephen Basil sold 10,000 shares of Climb Bio Inc at $5.81 per share, a transaction worth $58.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$5.81
Total value
$58.1K
InsiderThomas Stephen Basil
RoleDirector
CompanyClimb Bio Inc (CLYM)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after204,657
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2025.; The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.6200 to $6.1200, inclusive.